비교리스트

 카트 문의
시장보고서
상품코드
1572018

세계의 경피적 신장 결석 제거술 시장

Percutaneous Nephrolithotomy
발행일: | 리서치사: Global Industry Analysts, Inc. | 페이지 정보: 영문 93 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

경피적 신장 결석 제거술 시장은 2030년까지 4억 4,520만 달러에 달할 전망입니다.

2023년에 3억 2,840만 달러로 추정된 경피적 신장 결석 제거술 시장은 2030년에는 4억 4,520만 달러에 이르고, 예측 기간 동안 복합 연간 성장률(CAGR)은 4.4%로 성장할 것으로 예측됩니다.

미국 시장은 8,770만 달러로 추정되며 중국은 복합 연간 성장률(CAGR) 6.6%로 성장할 것으로 예측됩니다.

미국의 경피적 신장 결석 제거술 시장은 2023년 8,770만 달러로 추정됩니다. 세계 2위 경제대국인 중국은 예측 기간 동안 복합 연간 성장률(CAGR) 6.6%를 견인했으며, 2030년에는 예측시장 규모 9,360만 달러에 달할 것으로 예측되고 있습니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 복합 연간 성장률(CAGR)은 각각 2.5%와 4.2%로 예측되고 있습니다. 유럽에서는 독일이 복합 연간 성장률(CAGR) 2.7%로 성장할 것으로 예측됩니다.

세계의 경피적 신장 결석 제거술 시장 - 주요 동향과 촉진요인

경피적 신장 결석 제거술이란 무엇이며, 왜 큰 신결석 치료에 선정되어 있는가?

경피적 신장 결석 제거술(PCNL)은 체외 충격파 결석 파쇄술(ESWL)이나 요관경 검사 등의 저침습 기술로는 효과적인 치료를 할 수 없는 큰 신결석이나 복잡한 신결석을 제거하기 위해 사용되는 낮은 침습 수술입니다. 그러나 PCNL은 어떤 특징을 가지고 있으며, 왜 큰 신결석에 대해 선택되는가? 이 수술은 환자의 등을 일반적으로 1cm 미만의 작은 절개로 자르고 거기에서 신장으로 직접 신장 거울(특수 수술기구)을 삽입합니다. 이를 통해 외과의사는 결석을 시각화하고 기구를 사용하여 결석을 미세하게 부수고 제거할 수 있습니다. 치료 후 적절한 배수와 치유를 보장하기 위해 종종 튜브가 일시적으로 유치됩니다. PCNL은 직경 2cm 이상의 결석과 가시 모양의 결석, 신장의 해부학적으로 어려운 곳에 결석이 있는 경우에 특히 효과적입니다. 이 절차는 매우 효율적이며 대부분의 경우 결석 제거율은 90%를 초과하며 한 번의 치료로 큰 결석과 여러 결석을 치료하는 데 적합한 선택입니다. 개복 수술에 비해 PCNL은 수술 후 통증이 적고 입원 기간이 짧고 회복이 빠르다는 장점이 있으며 복잡한 신결석에 대한 결정적인 해결책이 필요한 환자에게 큰 이점을 제공합니다.

최근 기술 진보는 PCNL의 안전성과 효능을 어떻게 향상시켰는가?

경피적 신장 결석 제거술 분야는 절차의 안전성 프로파일, 정확성 및 결과를 크게 향상시킨 기술의 진보로부터 상당한 혜택을 받고 있습니다. 가장 주목할만한 진보 중 하나는 수술 기구의 소형화이며, 미니 PCNL이나 울트라 미니 PCNL로 불리는 더욱 소형의 신장경이나 액세스 관을 사용한 수술이 행해지게 되었습니다. 이 절차는 출혈의 위험을 줄이고 신장에 대한 외상을 최소화하므로 소아 환자와 성인 모두에게 적합합니다. 또 다른 중요한 혁신은 투시, 초음파, 실시간 CT 지침과 같은 고급 이미지 양식을 사용하여 해부학적으로 복잡한 경우에도 보다 정확한 결석 타겟팅과 더 안전한 신장으로 액세스가 가능합니다. 게다가, 레이저와 공압 장치를 포함한 새로운 결석 파쇄 장치는 단단한 결석을 파쇄하는 힘이 강화되고, 재수술의 필요성이 감소하고 있습니다. 이러한 에너지원은 효율을 향상시키고, 외과의사는 건강한 조직을 온존하면서 더 큰 결석을 보다 신속하게 깨뜨릴 수 있게 되었습니다. PCNL의 로봇 공학과 컴퓨터 지원 네비게이션의 통합도 시야에 들어가 있어 정확도를 더욱 높여 비뇨기과 의사의 학습 곡선을 단축할 것으로 기대되고 있습니다. 게다가 싱글스텝 확장 기술과 풍선 확장기로 신루조설 과정을 간소화하고 수술시간을 단축하고 합병증 발생률도 저하하고 있습니다. 이러한 진보로 PCNL은 더욱 안전할 뿐만 아니라 복잡한 신해부학적 구조, 단신, 여러 합병증을 가진 환자 등 보다 광범위한 환자 이미지에 적응할 수 있어 현대 비뇨기 과진의 유용성이 확대되고 있습니다.

왜 PCNL은 다양한 환자층에서 선호되는 치료법이 되고 있는가?

경피적 신장 결석 제거술의 채용은 다양한 환자층에서 꾸준히 증가하고 있으며, 이는 복잡한 결석증에 대한 범용성과 효능을 반영합니다. 성인 집단에서 PCNL은 큰 결석과 여러 결석을 관리하기위한 첫 번째 선택이되고 있으며, 비 침습적 방법이 실패한 경우의 첫 번째 선택이되었습니다. PCNL은 결석 제거의 성공률이 높고 재발률도 비교적 낮기 때문에 결석증에 대한 확실한 해결책을 요구하는 환자에게 매력적인 선택이 되고 있습니다. 소아비뇨기과는 소형화된 기구와 저위험 수술의 개발로 PCNL이 보급되고 있는 또 다른 분야입니다. 소아에서 PCNL은 그렇지 않으면 여러 치료가 필요한 증후성 결석 치료에 안전한 옵션을 제공합니다. 여러 합병증을 가진 경우가 많은 노인 환자도 개복 수술에 비해 합병증 발생률이 낮은 PCNL의 낮은 침습성으로 이익을 얻고 있습니다. 게다가, 말굽 신장이나 고발신 환자 등 해부학적으로 독특한 과제를 가진 환자가 PCNL을 받는 것이 증가하고 있는 것은 이 수술의 적응성의 높이와, 외과의가 특수한 장치를 이용 어 접근을 조정하는 능력 때문입니다. PCNL의 적용 범위는 비만 환자에게도 더욱 넓어지고, 경피적 접근은 보다 침습적인 선택보다 분명히 유리하며, 수술 부담과 회복 시간을 줄일 수 있습니다. 이와 같이 다양한 환자 집단에 PCNL이 널리 받아 들여지는 것은이 절차의 다양성의 증거 일뿐만 아니라 다양한 환자 집단의 특정 요구를 충족시키기 위해 PCNL 절차를 사용자 정의하는 비뇨기과 의사의 전문성이 높아지고 있다는 증거이기도 합니다.

경피적 신장 결석 제거술 시장의 성장을 뒷받침하고 있는 것은?

경피적 신장 결석 제거술 시장의 성장은 기술 진보, 신장 결석증의 이환율 증가, 낮은 침습 옵션에 대한 환자와 임상의의 의식 증가 등 여러 요인에 의해 야기됩니다. 주요 성장 요인 중 하나는 신 결석증의 세계 유병률의 상승이며, 이것은 식습관, 비만, 대사 이상과 같은 생활 습관 요인과 밀접한 관련이 있습니다. 신장 결석증이 연령층을 넘어 일반적이기 때문에 PCNL과 같은 효과적인 수술 치료에 대한 수요가 증가하고 있습니다. 또한 수술 장비 및 이미징 장비의 기술 혁신으로 PCNL의 안전성과 정확성이 향상되었으며 복잡한 해부학적 구조와 고위험 프로파일을 가진 환자를 포함하여 보다 광범위한 환자에게 실행 가능한 옵션 되어 있습니다. 소형화된 기구를 이용할 수 있게 된 것으로, 종래의 PCNL에서는 너무 침습적이라고 판단되고 있던 소아나 노인 의료를 중심으로, PCNL의 환자층이 퍼지고 있습니다. 또 다른 중요한 요인은 환자와 헬스케어 제공업체 사이에서 회복 시간 단축, 합병증 감소, 미용 결과 향상으로 이어지는 낮은 침습 수술에 대한 선호도가 증가하고 있다는 것입니다. 비뇨기과 전문센터 증가와 첨단 PCNL 기술의 훈련을 받은 숙련 외과의사의 존재도 시장 확대에 기여하고 있습니다. 게다가 새로운 PCNL 장비의 규제 당국에 의한 승인과 전문적인 수술 치료에 대한 접근성을 개선하는 것을 목표로 하는 지지적인 의료 정책이 보다 광범위한 보급을 촉진하고 있습니다. 로봇 시스템과 컴퓨터 지원 네비게이션의 통합은 정밀도 향상과 기술 습득 곡선의 단축을 약속하는 기술이기 때문에 시장을 더욱 추진할 계획입니다. 효과적이고 낮은 침습적인 신결석 치료에 대한 수요가 계속 증가하고 있는 가운데, 이러한 요인들이 종합적으로 PCNL 시장의 궤도를 형성하고, 이 시장을 강력한 성장으로 자리매김하고 있습니다.

조사 대상 기업 예(총 42건)

  • Boston Scientific Corporation
  • Cook Medical
  • Electro Medical Systems SA
  • innoMedicus AG
  • Karl Storz Se & Co. KG
  • Olympus Corporation
  • PolyDiagnost

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동
  • 아프리카

제4장 경쟁

BJH 24.10.24

Global Percutaneous Nephrolithotomy Market to Reach US$445.2 Million by 2030

The global market for Percutaneous Nephrolithotomy estimated at US$328.4 Million in the year 2023, is expected to reach US$445.2 Million by 2030, growing at a CAGR of 4.4% over the analysis period 2023-2030.

The U.S. Market is Estimated at US$87.7 Million While China is Forecast to Grow at 6.6% CAGR

The Percutaneous Nephrolithotomy market in the U.S. is estimated at US$87.7 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$93.6 Million by the year 2030 trailing a CAGR of 6.6% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.5% and 4.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.7% CAGR.

Global Percutaneous Nephrolithotomy Market - Key Trends and Drivers Summarized

What Is Percutaneous Nephrolithotomy and Why Is It the Preferred Treatment for Large Kidney Stones?

Percutaneous Nephrolithotomy (PCNL) is a minimally invasive surgical procedure used to remove large or complex kidney stones that cannot be effectively treated through less invasive techniques such as extracorporeal shock wave lithotripsy (ESWL) or ureteroscopy. But what makes PCNL distinct and why is it the go-to choice for large renal calculi? The procedure involves making a small incision, usually less than one centimeter, in the patient’s back through which a nephroscope—a specialized surgical instrument—is inserted directly into the kidney. This allows the surgeon to visualize the stones and use instruments to break them into smaller pieces for removal. A tube is often placed temporarily to ensure proper drainage and healing post-procedure. PCNL is particularly effective for stones larger than 2 cm in diameter, staghorn stones, or when stones are located in challenging anatomical locations within the kidney. The technique is highly efficient, with a stone clearance rate exceeding 90% in most cases, making it the preferred option for treating large or multiple stones in a single setting. Compared to open surgery, PCNL is associated with less postoperative pain, shorter hospital stays, and quicker recovery times, providing a significant advantage to patients who need a definitive solution to complex kidney stones.

How Have Recent Technological Advances Enhanced the Safety and Efficacy of PCNL?

The field of Percutaneous Nephrolithotomy has benefited immensely from technological advancements that have significantly improved the safety profile, precision, and outcomes of the procedure. One of the most noteworthy developments is the miniaturization of surgical instruments, leading to what is known as mini-PCNL or ultra-mini-PCNL, which uses even smaller nephroscopes and access tracts. This technique reduces the risk of bleeding and minimizes trauma to the kidney, making it suitable for pediatric patients and adults alike. Another pivotal innovation is the use of advanced imaging modalities, such as fluoroscopy, ultrasound, and real-time CT guidance, which allow for more precise stone targeting and safer access to the kidney, even in anatomically complex cases. Furthermore, new lithotripters, including laser and pneumatic devices, provide enhanced power for fragmenting hard stones, thus reducing the need for repeat procedures. These energy sources have improved efficiency, allowing surgeons to break down larger stones more quickly while preserving healthy tissue. The integration of robotics and computer-assisted navigation in PCNL is also on the horizon, promising to further increase accuracy and reduce the learning curve for urologists. Additionally, single-step dilation techniques and balloon dilators have simplified the process of creating the nephrostomy tract, decreasing operative time and lowering the incidence of complications. With these advancements, PCNL has become not only safer but also more adaptable to a wider range of patient profiles, including those with complex renal anatomy, solitary kidneys, or multiple co-morbidities, thereby expanding its utility in modern urological practice.

Why Is PCNL Becoming the Preferred Treatment Option Across Different Patient Demographics?

The adoption of Percutaneous Nephrolithotomy is steadily increasing across various patient demographics, reflecting its versatility and efficacy in addressing complex stone disease. In adult populations, PCNL is becoming the first-line option for managing large or multiple stones, as well as for cases where non-invasive methods have failed. The procedure’s high success rate in clearing stones, combined with its relatively low recurrence rate, makes it an attractive choice for patients seeking a definitive solution to their condition. Pediatric urology is another area where PCNL is gaining traction, thanks to the development of miniaturized instruments and lower-risk techniques. In children, PCNL offers a safe alternative for treating symptomatic stones that would otherwise require multiple procedures. Elderly patients, who often present with multiple comorbid conditions, also benefit from PCNL’s minimally invasive nature, which results in a lower overall complication rate compared to open surgery. Moreover, individuals with unique anatomical challenges, such as horseshoe kidneys or patients with a solitary kidney, are increasingly undergoing PCNL due to the procedure’s adaptability and the surgeon’s ability to tailor the approach using specialized equipment. The application of PCNL is further expanding to include obese patients, where the percutaneous approach offers a clear advantage over more invasive options, reducing surgical stress and recovery time. This broadening acceptance of PCNL across diverse patient groups is not just a testament to the procedure’s versatility but also to the growing expertise of urologists in customizing PCNL techniques to meet the specific needs of different patient populations.

What’s Fueling the Growth of the Percutaneous Nephrolithotomy Market?

The growth in the Percutaneous Nephrolithotomy market is driven by several factors, including technological advancements, the rising incidence of kidney stone disease, and increasing patient and clinician awareness of minimally invasive options. One of the primary growth drivers is the global rise in the prevalence of nephrolithiasis, which is closely linked to lifestyle factors such as dietary habits, obesity, and metabolic disorders. With kidney stone disease becoming more common across age groups, there is a growing demand for effective surgical treatments like PCNL. Additionally, technological innovations in surgical equipment and imaging modalities are enhancing the safety and precision of PCNL, making it a more viable option for a broader range of patients, including those with complex anatomy or high-risk profiles. The availability of miniaturized instruments has expanded the patient base for PCNL, particularly in pediatric and geriatric care, where traditional PCNL might have been deemed too invasive. Another key factor is the increasing preference among patients and healthcare providers for minimally invasive procedures, which are associated with shorter recovery times, fewer complications, and better cosmetic outcomes. The growth of specialized urology centers and the presence of skilled surgeons who are trained in advanced PCNL techniques are also contributing to market expansion. Moreover, regulatory approval of new PCNL devices and supportive healthcare policies aimed at improving access to specialized surgical care are encouraging more widespread adoption. The integration of robotic systems and computer-assisted navigation is poised to further propel the market, as these technologies promise to enhance precision and reduce the procedural learning curve. Collectively, these factors are shaping the trajectory of the PCNL market, positioning it for robust growth as the demand for effective and minimally invasive kidney stone treatments continues to rise.

Select Competitors (Total 42 Featured) -

  • Boston Scientific Corporation
  • Cook Medical
  • Electro Medical Systems SA
  • innoMedicus AG
  • Karl Storz Se & Co. KG
  • Olympus Corporation
  • PolyDiagnost

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Percutaneous Nephrolithotomy - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Prevalence of Kidney Stones Globally Spurs Demand for Minimally Invasive Surgical Techniques
    • Advancements in Imaging Technologies Strengthen the Business Case for PCNL in Complex Stone Management
    • Rising Adoption of Miniaturized Instruments Expands Addressable Market Opportunity in Pediatric and Geriatric Segments
    • Integration of Robotics and Computer-Assisted Navigation Propels Market Growth in High-Precision Stone Removal
    • Improved Post-Operative Outcomes and Reduced Recovery Times Sustain Growth of PCNL in High-Risk Patient Groups
    • Surge in Health Awareness and Early Diagnosis Accelerates Demand for Surgical Stone Management Solutions
    • Technological Innovations in Lithotripters and Energy Sources Strengthen PCNL's Position in the Kidney Stone Treatment Spectrum
    • Rising Geriatric Population and Associated Urological Disorders Expand the Addressable Market for PCNL
    • Increasing Medical Tourism in Emerging Markets Generates New Opportunities for PCNL Procedures
    • High Incidence of Lifestyle-Related Risk Factors for Nephrolithiasis Creates Sustained Demand for Surgical Interventions
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Percutaneous Nephrolithotomy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Percutaneous Nephrolithotomy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Percutaneous Nephrolithotomy Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Percutaneous Nephrolithotomy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 5: USA Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 6: USA Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • CANADA
    • TABLE 7: Canada Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 8: Canada Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • JAPAN
    • Percutaneous Nephrolithotomy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 9: Japan Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 10: Japan Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • CHINA
    • Percutaneous Nephrolithotomy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 11: China Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 12: China Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • EUROPE
    • Percutaneous Nephrolithotomy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 13: Europe Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 14: Europe Historic Review for Percutaneous Nephrolithotomy by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 15: Europe 16-Year Perspective for Percutaneous Nephrolithotomy by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
  • FRANCE
    • Percutaneous Nephrolithotomy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 16: France Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 17: France Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • GERMANY
    • Percutaneous Nephrolithotomy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 18: Germany Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 19: Germany Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • ITALY
    • TABLE 20: Italy Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 21: Italy Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • UNITED KINGDOM
    • Percutaneous Nephrolithotomy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 22: UK Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 23: UK Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • SPAIN
    • TABLE 24: Spain Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 25: Spain Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • RUSSIA
    • TABLE 26: Russia Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Russia Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • REST OF EUROPE
    • TABLE 28: Rest of Europe Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 29: Rest of Europe Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • ASIA-PACIFIC
    • Percutaneous Nephrolithotomy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 30: Asia-Pacific Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 31: Asia-Pacific Historic Review for Percutaneous Nephrolithotomy by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 32: Asia-Pacific 16-Year Perspective for Percutaneous Nephrolithotomy by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
  • AUSTRALIA
    • Percutaneous Nephrolithotomy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 33: Australia Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 34: Australia Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • INDIA
    • Percutaneous Nephrolithotomy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 35: India Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: India Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • SOUTH KOREA
    • TABLE 37: South Korea Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 38: South Korea Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • REST OF ASIA-PACIFIC
    • TABLE 39: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 40: Rest of Asia-Pacific Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • LATIN AMERICA
    • Percutaneous Nephrolithotomy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 41: Latin America Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 42: Latin America Historic Review for Percutaneous Nephrolithotomy by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: Latin America 16-Year Perspective for Percutaneous Nephrolithotomy by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 44: Argentina Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Argentina Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • BRAZIL
    • TABLE 46: Brazil Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 47: Brazil Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • MEXICO
    • TABLE 48: Mexico Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 49: Mexico Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • REST OF LATIN AMERICA
    • TABLE 50: Rest of Latin America Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Rest of Latin America Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • MIDDLE EAST
    • Percutaneous Nephrolithotomy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 52: Middle East Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 53: Middle East Historic Review for Percutaneous Nephrolithotomy by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 54: Middle East 16-Year Perspective for Percutaneous Nephrolithotomy by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
  • IRAN
    • TABLE 55: Iran Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 56: Iran Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • ISRAEL
    • TABLE 57: Israel Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 58: Israel Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • SAUDI ARABIA
    • TABLE 59: Saudi Arabia Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Saudi Arabia Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • UNITED ARAB EMIRATES
    • TABLE 61: UAE Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 62: UAE Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • REST OF MIDDLE EAST
    • TABLE 63: Rest of Middle East Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 64: Rest of Middle East Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • AFRICA
    • Percutaneous Nephrolithotomy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 65: Africa Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Africa Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR

IV. COMPETITION

비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제